Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Soleno Therapeutics, Inc. - Common Stock (NQ:SLNO)

33.62 +0.23 (+0.69%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 921,852
Open 33.24
Bid (Size) 33.62 (100)
Ask (Size) 35.05 (100)
Prev. Close 33.39
Today's Range 33.18 - 34.35
52wk Range 32.63 - 90.32
Shares Outstanding 8,168,788
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Conducting Sham Clinical Trials: Levi & Korsinsky
From Levi & Korsinsky, LLP
Via Business Wire
News headline image
Soleno Therapeutics, Inc. (SLNO) Class Action Lawsuit Seeks Recovery for Investors; May 5, 2026, Deadline - Contact Kessler Topaz Meltzer & Check, LLP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit Retirement

Performance

YTD
-28.7%
-28.7%
1 Month
-12.7%
-12.7%
3 Month
-32.7%
-32.7%
6 Month
-34.3%
-34.3%
1 Year
-32.3%
-32.3%

More News

Read More
Soleno Therapeutics, Inc. (SLNO) Class Action Lawsuit Seeks Recovery for Investors; May 5, 2026, Deadline - Contact Kessler Topaz Meltzer & Check, LLP
Via TheNewswire.com
Topics Fraud Lawsuit Retirement
Soleno Therapeutics Inc (NASDAQ:SLNO) Emerges as a Potential Fair-Value Opportunity ↗
Via Chartmill
News headline image
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Soleno Therapeutics, Inc. (SLNO)
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Soleno Therapeutics, Inc. (SLNO) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit
Via NewMediaWire
Topics Fraud Lawsuit Retirement
News headline image
Soleno Therapeutics, Inc. (SLNO) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit
Via TheNewswire.com
Topics Fraud Lawsuit Retirement
News headline image
Deadline Alert: Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Camping World Holdings, Inc. (NYSE: CWH); Soleno Therapeutics, Inc. (NASDAQ: SLNO); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
News headline image
Soleno Therapeutics, Inc. (SLNO) Investors: May 5, 2026, Deadline in Securities Fraud Class Action Lawsuit
Via TheNewswire.com
Topics Fraud Lawsuit Retirement
News headline image
Soleno Therapeutics, Inc. (SLNO) Investors: May 5, 2026, Deadline in Securities Fraud Class Action Lawsuit
Via NewMediaWire
Topics Fraud Lawsuit Retirement
News headline image
Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Camping World Holdings, Inc. (NYSE: CWH); EOS Energy Enterprise, Inc. (NASDAQ: EOSE); and Soleno Therapeutics, Inc. (NASDAQ: SLNO): Grabar Law Office Investigates Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
News headline image
SLNO ALERT: Securities Class Action Lawsuit Against Soleno Therapeutics, Inc. (SLNO) - Contact Kaplan Fox Before Deadline on May 5, 2026
Via NewMediaWire
Topics Lawsuit
News headline image
SLNO ALERT: Securities Class Action Lawsuit Against Soleno Therapeutics, Inc. (SLNO) - Contact Kaplan Fox Before Deadline on May 5, 2026
Via TheNewswire.com
Topics Lawsuit
News headline image
SLNO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Securities Class Action Filed Against Soleno Therapeutics, Inc. – Investors Encouraged to Contact Kirby McInerney LLP
From Kirby McInerney LLP
Via Business Wire
News headline image
Deadline Approaching: Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
SLNO CLASS ACTION DEADLINE: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Soleno Therapeutics, Inc. (NASDAQ: SLNO) and Lead Plaintiff Deadline on May 5, 2026
Via NewMediaWire
Topics Lawsuit
News headline image
SLNO CLASS ACTION DEADLINE: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Soleno Therapeutics, Inc. (NASDAQ: SLNO) and Lead Plaintiff Deadline on May 5, 2026
Via TheNewswire.com
Topics Lawsuit
News headline image
SLNO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
Soleno Therapeutics Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action filed by Robbins Geller Rudman & Dowd LLP
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
News headline image
Soleno Therapeutics, Inc. (SLNO) Investors: May 5, 2026, Deadline in Securities Fraud Class Action Lawsuit – Contact Kessler Topaz Meltzer & Check, LLP
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
News headline image
Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages Soleno Therapeutics, Inc. (SLNO) Shareholders To Inquire About Securities Fraud Class Action
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire

Frequently Asked Questions

Is Soleno Therapeutics, Inc. - Common Stock publicly traded?
Yes, Soleno Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Soleno Therapeutics, Inc. - Common Stock trade on?
Soleno Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Soleno Therapeutics, Inc. - Common Stock?
The ticker symbol for Soleno Therapeutics, Inc. - Common Stock is SLNO on the Nasdaq Stock Market
What is the current price of Soleno Therapeutics, Inc. - Common Stock?
The current price of Soleno Therapeutics, Inc. - Common Stock is 33.62
When was Soleno Therapeutics, Inc. - Common Stock last traded?
The last trade of Soleno Therapeutics, Inc. - Common Stock was at 03/17/26 04:00 PM ET
What is the market capitalization of Soleno Therapeutics, Inc. - Common Stock?
The market capitalization of Soleno Therapeutics, Inc. - Common Stock is 274.63M
How many shares of Soleno Therapeutics, Inc. - Common Stock are outstanding?
Soleno Therapeutics, Inc. - Common Stock has 275M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.